Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease

Affiliations

¹ Department of Neurology at The Feinberg School of Medicine at Northwestern University and The Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
² Department of Neurology at Stanford University, Department of Neurology, Division of Neuro-oncology, Stanford, California, USA.

Editorial

Priya Kumthekar et al. Neuro Oncol. 2022.

. 2022 Oct 3;24(10):1687-1688.

doi: 10.1093/neuonc/noac142.

¹ Department of Neurology at The Feinberg School of Medicine at Northwestern University and The Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
² Department of Neurology at Stanford University, Department of Neurology, Division of Neuro-oncology, Stanford, California, USA.

No abstract available

Comment on

A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
Law V, Chen Z, Vena F, Smalley I, Macaulay R, Evernden BR, Tran N, Pina Y, Puskas J, Caceres G, Bayle S, Johnson J, Liu JKC, Etame A, Vogelbaum M, Rodriguez P, Duckett D, Czerniecki B, Chen A, Smalley KSM, Forsyth PA. Law V, et al. Neuro Oncol. 2022 Oct 3;24(10):1673-1686. doi: 10.1093/neuonc/noac054. Neuro Oncol. 2022. PMID: 35213727 Free PMC article.

1. Rygard J, Polvlsen CO. Heterotransplantation of a human malignant tumour to “Nude” mice. Acta Pathol Microbiol Scand. 1969;77(4):758–760. - PubMed
1. Vaubel RA, Tian S, Remonde D, et al. Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases. Clin Cancer Res. 2020;. 26 (5):1094–1104. - PMC - PubMed
1. Valiente M, Van Swearingen AED, Anders CK, et al. Brain metastasis cell lines panel: a public resource of organotropic cell lines. Cancer Res. 2020;80(20):4314–4323. - PMC - PubMed
1. Boire A, Zou Y, Shieh J, et al. Complement component 3 adapt the cerebrospinal fluid for leptomeningeal metastasis. Cell. 2017;168(6):1101–1113.e13. - PMC - PubMed
1. Law V, Chen Z, Vena F, et al. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma. Neuro Oncol. 2022; 24(10):1673–1686. - PMC - PubMed